毛兰素的药理学作用研究进展  

Research Progress on Pharmacological Activities of Erianin

作　　者：李明[1] 赵远 马萍 袁红军 唐文如[1] 盛苗苗 LI Ming;ZHAO Yuan;MA Ping;YUAN Hongjun;TANG Wenru;SHNEG Miaomiao(Laboratory of Molecular Genetics of Aging&Tumor,Kunming University of Science and Technology,Kunming 650500,China)

机构地区：[1]昆明理工大学,衰老与肿瘤分子遗传学实验室,昆明650500

出　　处：《中国细胞生物学学报》2022年第2期399-404,共6页Chinese Journal of Cell Biology

基　　金：云南省科技项目基金(批准号:202101AT070071)资助的课题。

摘　　要：毛兰素是从兰科石斛属植物中提取的小分子联苄类化合物,现已发现其具有诱导细胞程序性死亡、抑制血管生成、抗氧化等多种生物学功能,并且具有治疗包括肿瘤在内的多种疾病的潜力,该文就近年来毛兰素药理活性的研究进展作一综述。Erianin is a small molecule bibenzyl compound extracted from the Dendrobium genus of Orchidaceae.It has been found that it has a variety of functions,inducing programmed cell death,inhibiting angiogenesis,anti-oxidation,and so on.And erianinl has the potential to treat a variety of diseases,including cancer.This paper reviews the research progress on the pharmacological activities of Erianin in recent years.

关 键 词：毛兰素 药理作用 分子机制 

分 类 号：R285[医药卫生—中药学]